Cigna (CI) | Financial Analysis & Statements
The Cigna Group Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
72.4B
Net Income
1.3B
1.76%
EPS (Diluted)
$4.64
Balance Sheet Metrics
Total Assets
157.9B
Total Liabilities
116.0B
Shareholders Equity
41.9B
Debt to Equity
2.77
Cash Flow Metrics
Operating Cash Flow
5.7B
Free Cash Flow
5.8B
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Cigna Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 274.9B | 244.4B | 195.2B | 180.0B | 174.3B |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 14.6B | 14.8B | 14.8B | 13.2B | 13.0B |
| Other Operating Expenses | 215.0B | 182.5B | 133.8B | 124.8B | 117.6B |
| Total Operating Expenses | 229.6B | 197.4B | 148.6B | 138.0B | 130.6B |
| Operating Income | - | - | - | - | - |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 1.4B | 1.4B | 1.4B | 1.2B | 1.2B |
| Other Non-Operating Income | 216.7B | 185.4B | 137.2B | 128.6B | 121.4B |
| Pre-tax Income | 7.8B | 5.3B | 5.5B | 8.4B | 6.8B |
| Income Tax | 1.5B | 1.5B | 141.0M | 1.6B | 1.4B |
| Effective Tax Rate % | 19.2% | 28.3% | 2.6% | 19.2% | 20.2% |
| Net Income | 6.3B | 3.8B | 5.4B | 6.8B | 5.4B |
| Net Margin % | 2.3% | 1.5% | 2.8% | 3.8% | 3.1% |
| Key Metrics | |||||
| EBITDA | - | - | - | - | - |
| EPS (Basic) | $22.18 | $12.12 | $17.57 | $21.30 | $15.89 |
| EPS (Diluted) | $22.18 | $12.12 | $17.39 | $21.30 | $15.75 |
| Basic Shares Outstanding | 268563000 | 283218000 | 293892000 | 313065000 | 337962000 |
| Diluted Shares Outstanding | 268563000 | 283218000 | 293892000 | 313065000 | 337962000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Cigna Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 7.7B | 7.6B | 7.8B | 5.9B | 5.1B |
| Short-term Investments | 970.0M | 665.0M | 925.0M | 905.0M | 920.0M |
| Accounts Receivable | 32.6B | 30.4B | 23.4B | 22.4B | 19.6B |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | - | - | - | - | - |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | - |
| Goodwill | 118.4B | 118.2B | 119.4B | 124.1B | 125.8B |
| Intangible Assets | 28.6B | 29.4B | 30.9B | 32.5B | 34.2B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - |
| Total Assets | 157.9B | 155.9B | - | - | - |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 10.7B | 9.3B | 8.6B | 7.8B | 6.7B |
| Short-term Debt | 592.0M | 3.0B | 2.8B | 3.0B | 2.5B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | - | - | - | - | - |
| Non-Current Liabilities | |||||
| Long-term Debt | 30.9B | 28.9B | 28.2B | 28.1B | 31.1B |
| Deferred Tax Liabilities | 7.1B | 7.0B | 7.2B | 7.8B | 8.3B |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | - | - | - | - | - |
| Total Liabilities | 116.0B | 114.6B | - | - | - |
| Equity | |||||
| Common Stock | 4.0M | 4.0M | 4.0M | 4.0M | 4.0M |
| Retained Earnings | 47.9B | 43.5B | 41.7B | 37.9B | 32.6B |
| Treasury Stock | 35.1B | 31.4B | 24.2B | 21.8B | 14.2B |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 41.9B | 41.2B | 46.4B | 44.8B | 47.2B |
| Key Metrics | |||||
| Total Debt | 31.5B | 32.0B | 30.9B | 31.1B | 33.7B |
| Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Cigna Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 6.3B | 3.8B | 5.4B | 6.8B | 5.4B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.0B | 1.8B | 2.9B | 920.0M | -1.7B |
| Operating Cash Flow | 5.6B | 5.5B | 6.6B | 7.2B | 3.7B |
| Investing Activities | |||||
| Capital Expenditures | -1.2B | -1.4B | -1.6B | -1.3B | -1.2B |
| Acquisitions | 2.4B | 390.0M | -434.0M | 4.8B | -1.9B |
| Investment Purchases | -7.2B | -2.7B | -5.5B | -4.3B | -6.1B |
| Investment Sales | 2.7B | 2.4B | 2.6B | 4.1B | 5.6B |
| Investing Cash Flow | -4.5B | -2.2B | -5.2B | 3.2B | -3.5B |
| Financing Activities | |||||
| Share Repurchases | -3.6B | -7.0B | -2.3B | -7.6B | -7.7B |
| Dividends Paid | -1.6B | -1.6B | -1.4B | -1.4B | -1.3B |
| Debt Issuance | 6.5B | 4.5B | 1.5B | 0 | 4.3B |
| Debt Repayment | -6.2B | -3.0B | -3.0B | -500.0M | -4.6B |
| Financing Cash Flow | -6.4B | -7.6B | -4.3B | -11.2B | -8.2B |
| Free Cash Flow | 8.4B | 9.0B | 10.2B | 7.4B | 6.0B |
| Net Change in Cash | -5.4B | -4.4B | -2.9B | -849.0M | -8.0B |
Cash Flow Trend
Cigna Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.61
Forward P/E
8.37
Price to Book
1.77
Price to Sales
0.27
PEG Ratio
-1.32
Profitability Ratios
Profit Margin
2.17%
Operating Margin
3.53%
Return on Equity
15.13%
Return on Assets
4.09%
Financial Health
Current Ratio
0.85
Debt to Equity
75.14
Beta
0.27
Per Share Data
EPS (TTM)
$22.18
Book Value per Share
$158.33
Revenue per Share
$1,030.58
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CI | 72.7B | 12.61 | 1.77 | 15.13% | 2.17% | 75.14 |
| UnitedHealth | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
| CVS Health | 101.1B | 55.65 | 1.31 | 2.29% | 0.44% | 106.06 |
| Elevance Health | 76.4B | 13.19 | 1.67 | 13.25% | 2.84% | 74.39 |
| Humana | 25.8B | 21.84 | 1.47 | 7.04% | 0.92% | 74.82 |
| Centene | 20.2B | 8.06 | 1.01 | -28.68% | -3.79% | 90.56 |
Financial data is updated regularly. All figures are in the company's reporting currency.






